Back to companies

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. Its product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and clinical nutrition products. The company's therapeutic expertise covers areas of blood volume substitution, fluid management, anesthesia, critical illness, liver insufficiency, renal insufficiency, maldigestion or malabsorption, diabetes mellitus and pediatrics. Its products and services are indicated for the treatment of critically and chronically ill patients. Fresenius Kabi conducts sales and marketing operations through direct offices worldwide. The company has its facilities in Europe, North America, Latin America, Asia Pacific and Africa. Fresenius Kabi is headquartered in Bad Homburg, Germany.

Headquarters Germany

Address Else-Kroner-Strasse 1, Bad Homburg, Hessen, 61352


Telephone 49 6172 686 0

No of Employees 40,519

Industry Medical Equipment

Revenue (2020) $8.0B

   

   

Explore premium data & analytics

290+

Marketed Drugs

Understand Fresenius Kabi AG’s commercialized product portfolio to stay one step ahead of the market.

50+

Clinical Trials

Determine Fresenius Kabi AG go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

20+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

17+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Fresenius Kabi AG’s relevant decision makers and contact details.

13+

Pipeline Drugs

Identify which of Fresenius Kabi AG’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

13+

Catalyst Calendar

Proactively evaluate Fresenius Kabi AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
Infusion Therapy: Transition Management: Voluven
Blood Volume Substitutes / HES: Home Therapy Volulyte
Voluven 6% HyperHAES
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Acquisitions/Mergers/Takeovers In May, the company acquired the US-based Ivenix.
2022 Contracts/Agreements In March, the company entered into an agreement to acquire 55% stake in mAbxience from Insud Pharma.
2020 Contracts/Agreements In November, the company and Vifor Fresenius Medical Care Renal Pharma entered into an agreement to develop, register and distribute Veltassa for the treatment of hyperkalemia in the People’s Republic of China.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Fresenius Kabi AG Abbott Laboratories Becton Dickinson and Co Teva Pharmaceutical Industries Ltd Sandoz Inc
Headquarters Germany United States of America United States of America Israel United States of America
City Bad Homburg Abbott Park Franklin Lakes Tel Aviv Princeton
State/Province Hessen Illinois New Jersey Tel Aviv New Jersey
No. of Employees 40,519 113,000 75,000 37,037 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Stephan Sturm Chairman Executive Board - -
Michael Sen Chief Executive Officer Senior Management 2021 52
Rachel Empey Deputy Chair Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer